Funding
Supported by the Fundamental Research Funds for the Central Universities(Grant no. 2019jbkyzy002,lzujbky-2019-ct02,2020jbkyzx001,lzujbky-2020-kb20)
Fig.1 Flow diagram;
Fig.2a, b Risk of bias
Fig.3 Association between various phytoestrogens with the effectiveness of depression.
e-Fig 1. The result of sensitivity analysis
e-Fig.2 The trim and -fill funnel plot.
e-Fig.3 Association between isoflavone and lignans groups with the effectiveness of menopausal women to remission depression in different evaluation scales
e-Fig.4 Association between three intake doses’ group with the effectiveness of menopausal women to remission depression.
e-Fig. 5 Association between various scales with the effectiveness of menopausal women to remission depression.
e-Fig.6 Association between isoflavone and lignans groups with the effectiveness of menopausal women to remission depression in different evaluation scales except for KMI and GCS scales.
e-Fig.7 Association between three intake doses ’groups with the effectiveness of menopausal women to remission depression in different evaluation scales except for KMI and GCS scales.
e-Fig.8 Association between eight countries with the effectiveness of menopausal women to remission depression.
Table1. Characteristic of the studies included in the meta-analysis
Table2. The adverse events in all included studies
Reference
1. Glisic M, Kastrati N, Musa J, et al. Phytoestrogen supplementation and body composition in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials. Maturitas.2018;115:74-83.
2. Aghamiri V, Mirghafourvand M, Mohammad-Alizadeh-Charandabi S, Nazemiyeh H. The effect of Hop (Humulus lupulus L.) on early menopausal symptoms and hot flashes: A randomized placebo-controlled trial.Complement Ther Clin Pract. 2016;23:130-135.
3. Gerbarg PL, Brown RP. Pause menopause with Rhodiola rosea, a natural selective estrogen receptor modulator. Phytomedicine : international journal of phytotherapy and phytopharmacology.2016;23(7):763-769.
4. Hale G, Bievre M, Hughes C. Exploring the role of progestins and phytoestrogens in menopause. Integrative Medicine.1999;2(2-3):133-141.
5. Llaneza P, García-Portilla MP, Llaneza-Suárez D, Armott B, Pérez-López FR. Depressive disorders and the menopause transition.Maturitas. 2012;71(2):120-130.
6. Perez-Lopez FR, Perez-Roncero G, Fernandez-Inarrea J, et al. Resilience, depressed mood, and menopausal symptoms in postmenopausal women. Menopause (New York, NY). 2014;21(2):159-164.
7. Johnston E, Johnson S, McLeod P, Johnston M. The relation of body mass index to depressive symptoms. Canadian journal of public health = Revue canadienne de sante publique. 2004;95(3):179-183.
8. Lee JY, Park YK, Cho KH, et al. Suicidal ideation among postmenopausal women on hormone replacement therapy: The Korean National Health and Nutrition Examination Survey (KNHANES V) from 2010 to 2012.Journal of affective disorders. 2016;189:214-219.
9. Birkhäuser M. Menopause, oestrogen deficiency and depression.Archives of Women’s Mental Health. 2011;14:S97.
10. Faubion SS, Litin SC, Bundrick JB. Clinical Pearls in women’s health. Disease-a-Month. 2017;63(6):149-157.
11. Finnell JE, Lombard CM, Moffitt CM, et al. The role of estradiol on social stress induced depressive-like behavior and neuroinflammation in females. FASEB Journal. 2017;31(1).
12. Al-Safi ZA, Santoro N. Menopausal hormone therapy and menopausal symptoms. Fertility and Sterility. 2014;101(4):905-915.
13. Morrison MF, Kallan MJ, Ten Have T, Katz I, Tweedy K, Battistini M. Lack of efficacy of estradiol for depression in postmenopausal women: a randomized, controlled trial. Biol Psychiatry.2004;55(4):406-412.
14. Bai F, Ling J, Esoimeme G, et al. A systematic review of questionnaires about patient’s values and preferences in clinical practice guidelines. Patient preference and adherence.2018;12:2309-2323.
15. Lee HW, Jun JH, Kil KJ, Ko BS, Lee CH, Lee MS. Herbal medicine (Danggui Shaoyao San) for treating primary dysmenorrhea: A systematic review and meta-analysis of randomized controlled trials.Maturitas. 2016;85:19-26.
16. Atteritano M, Mazzaferro S, Bitto A, et al. Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study.Osteoporosis international. 2014;25(3):1123‐1129.
17. Power KA, Thompson LU. Can the combination of flaxseed and its lignans with soy and its isoflavones reduce the growth stimulatory effect of soy and its isoflavones on established breast cancer?Molecular nutrition & food research. 2007;51(7):845-856.
18. Lipovac M, Chedraui P, Gruenhut C, Gocan A, Stammler M, Imhof M. Improvement of postmenopausal depressive and anxiety symptoms after treatment with isoflavones derived from red clover extracts.Maturitas. 2010;65(3):258-261.
19. Keshavarz Z, Golezar S, Hajifoghaha M, Alizadeh S. The effect of phytoestrogens on menopause symptoms: A systematic review. Journal of Isfahan Medical School. 2018;36(477):446-459.
20. de Sousa-Muñoz RL, Filizola RG. Efficacy of soy isoflavones for depressive symptoms of the climacteric syndrome. Maturitas.2009;63(1):89-93.
21. Su BYW, Tung TH, Chien WH. Effects of phytoestrogens on depressive symptoms in climacteric women: A meta-analysis of randomized controlled trials. Journal of Alternative and Complementary Medicine.2018;24(8):850-851.
22. Norris SL, Meerpohl JJ, Akl EA, et al. The skills and experience of GRADE methodologists can be assessed with a simple tool. J Clin Epidemiol. 2016;79:150-158 e151.
23. Chen Y, Yang K, Marusic A, et al. A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement. Ann Intern Med.2017;166(2):128-132.
24. Ge L, Tian JH, Li YN, et al. Association between prospective registration and overall reporting and methodological quality of systematic reviews: a meta-epidemiological study. J Clin Epidemiol. 2018;93:45-55.
25. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in medicine. 2002;21(11):1539-1558.
26. Xiu-xia L, Ya Z, Yao-long C, Ke-hu Y, Zong-jiu Z. The reporting characteristics and methodological quality of Cochrane reviews about health policy research. Health Policy. 2015;119(4):503-510.
27. Flemyng E, Dwan K, Moore TH, Page MJ, Higgins JP. Risk of Bias 2 in Cochrane Reviews: a phased approach for the introduction of new methodology. The Cochrane database of systematic reviews.2020;10:Ed000148.
28. Rosenthal R. The ”File Drawer Problem” and Tolerance for Null Results. Psychological Bulletin. 1979;86(3):638-641.
29. Page MJ, Sterne JAC, Higgins JPT, Egger M. Investigating and dealing with publication bias and other reporting biases in meta-analyses of health research: A review. Research synthesis methods. 2020.
30. Duval S, Tweedie R. Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis.Biometrics. 2000;56(2):455-463.
31. Cheung M, Ho R, Lim Y, Mak A. Conducting a meta-analysis: basics and good practices. International journal of rheumatic diseases.2012;15(2):129-135.
32. Ishiwata N, Melby MK, Mizuno S, Watanabe S. New equol supplement for relieving menopausal symptoms: randomized, placebo-controlled trial of Japanese women. Menopause (New York, NY). 2009;16(1):141-148.
33. Hirose A, Terauchi M, Akiyoshi M, Owa Y, Kato K, Kubota T. Low-dose isoflavone aglycone alleviates psychological symptoms of menopause in Japanese women: a randomized, double-blind, placebo-controlled study.Archives of Gynecology and Obstetrics. 2016;293(3):609-615.
34. Park JY, Kim KH. A randomized, double-blind, placebo-controlled trial of Schisandra chinensis for menopausal symptoms. Climacteric : the journal of the International Menopause Society.2016;19(6):574-580.
35. Shamshad Begum S, Jayalakshmi HK, Vidyavathi HG, et al. A Novel Extract of Fenugreek Husk (FenuSMART™) Alleviates Postmenopausal Symptoms and Helps to Establish the Hormonal Balance: A Randomized, Double-Blind, Placebo-Controlled Study. Phytotherapy Research.2016;30(11):1775-1784.
36. Evans HM, Howe PRC, Wong RHX. Effects of Resveratrol on Cognitive Performance, Mood and Cerebrovascular Function in Post-Menopausal Women; A 14-Week Randomised Placebo-Controlled Intervention Trial.Nutrients. 2017;9(1).
37. Tice JA, Ettinger B, Ensrud K, Wallace R, Blackwell T, Cummings SR. Phytoestrogen supplements for the treatment of hot flashes: the Isoflavone Clover Extract (ICE) Study: a randomized controlled trial.Jama. 2003;290(2):207-214.
38. Cagnacci A, Arangino S, Renzi A, Zanni AL, Malmusi S, Volpe A. Kava-Kava administration reduces anxiety in perimenopausal women.Maturitas. 2003;44(2):103-109.
39. Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: has the gold standard become a lead weight?Am J Psychiatry. 2004;161(12):2163-2177.
40. Kanda F, Oishi K, Sekiguchi K, et al. Characteristics of depression in Parkinson’s disease: evaluating with Zung’s Self-Rating Depression Scale. Parkinsonism & related disorders. 2008;14(1):19-23.
41. Pollock V, Cho DW, Reker D, Volavka J. Profile of Mood States: the factors and their physiological correlates. The Journal of nervous and mental disease. 1979;167(10):612-614.
42. Travers C, O’Neill SM, King R, Battistutta D, Khoo SK. Greene Climacteric Scale: norms in an Australian population in relation to age and menopausal status. Climacteric : the journal of the International Menopause Society. 2005;8(1):56-62.
43. Alder E. The Blatt-Kupperman menopausal index: a critique.Maturitas. 1998;29(1):19-24.
44. Bu L, Lephart ED. Soy isoflavones modulate the expression of BAD and neuron-specific beta III tubulin in male rat brain. Neurosci Lett. 2005;385(2):153-157.
45. Oxfeldt M, Dalgaard LB, Risikesan J, Johansen FT, Hansen M. Influence of Fermented Red Clover Extract on Skeletal Muscle in Early Postmenopausal Women: A Double-Blinded Cross-Over Study.Nutrients. 2020;12(11).
46. Izumi T, Piskula MK, Osawa S, et al. Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans.The Journal of nutrition. 2000;130(7):1695-1699.
47. Kaari C, Haidar MA, Júnior JM, et al. Randomized clinical trial comparing conjugated equine estrogens and isoflavones in postmenopausal women: a pilot study. Maturitas. 2006;53(1):49-58.
48. Davis SR, Briganti EM, Chen RQ, Dalais FS, Bailey M, Burger HG. The effects of Chinese medicinal herbs on postmenopausal vasomotor symptoms of Australian women. A randomised controlled trial. Med J Aust.2001;174(2):68-71.
49. Mason C, de Dieu Tapsoba J, Duggan C, Wang CY, Alfano CM, McTiernan A. Eating behaviors and weight loss outcomes in a 12-month randomized trial of diet and/or exercise intervention in postmenopausal women.The international journal of behavioral nutrition and physical activity. 2019;16(1):113.
50. Yang K. Evidence-based social science: the origin, development and prospects. . Libr Inf. 2018(03):1-10.